Chapter 415
Chapter 415
As the CEO of the group, Anna naturally has to worry about this issue.
First, we need to find out the type of new drug Chen Xuan is developing to determine whether it will pose a threat to Novartis, and then determine whether it can bring benefits to Novartis.
Anna needs to consider all these points first, so she must obtain important information about Chen Xuan's new drug in advance.
In fact,
Now people who do this,
But Anna wasn't the only one.
But countless pharmaceutical companies around the world are doing the same thing.
After hearing the news, pharmaceutical companies at home and abroad did not dare to take it lightly.
The miracles created by Chen Xuan were so dazzling that no one dared to underestimate him, for fear that he would create another miracle.
Many pharmaceutical companies share Anna's concerns, fearing that the new drugs he develops will become their competitors.
If this new drug is for a disease that has not yet been conquered, at most it will just make these pharmaceutical companies look very embarrassed. In comparison, they will be exposed as having no R&D capabilities, but in reality there will be no loss.
But if the new drug he develops happens to be a disease treatment drug owned by these pharmaceutical companies, then the situation will not be optimistic.
Even if it is a similar drug to a blockbuster drug, it would be bad news for these pharmaceutical companies.
After all, if Chen Xuan’s new drug is more effective than theirs, what market will they have?
Medicines are different from ordinary commodities.
If the quality of ordinary goods is not good, you can still engage in price wars.
But is a price war on pharmaceuticals useful?
The purpose of taking medicine is to save lives!
Is it just for cheapness?
Of course, patients want to take the best medicine.
Get well soon.
The same is true for doctors.
Only by curing patients as quickly as possible can they demonstrate their medical skills.
Therefore, once this new drug comes out, it will easily become the industry leader.
It is also based on these reasons.
This is what makes so many pharmaceutical companies worried.
They were afraid that Chen Xuan’s new medicine would suddenly replace them.
If this new drug is also a specific drug for liver cancer and lung cancer, they can't imagine what the situation will be like.
As a result, many pharmaceutical companies began to send people to investigate, each of them wanting to know what type of drug Chen Xuan’s new drug was.
……
……
On Chen Xuan's side,
But he didn't realize that his words had just been spoken and were known to the whole world.
Even many pharmaceutical giants made arrangements at the first opportunity to conduct targeted investigations on his new drugs.
But it doesn't matter even if you know, because the outcome of the matter is already determined.
"Mr. Chen, do you think Antai Pharmaceutical Group will apply for clinical trials for other drugs?"
"Then may I ask if this drug is the new drug that you mentioned a while ago that is in the development stage?"
Another female reporter at the scene asked.
Compared with the previous reporter, she looked much more pleasing to the eye. At least there was no 10cm thick wall dust on her face, and the questions she asked were not targeted.
But this issue is very critical and first-hand information can be obtained.
Antai Pharmaceutical Group is preparing to apply for clinical trials. Is this a new drug developed by Chen Xuan, or a drug acquired from outside?
But no matter which possibility it is, they'd better confirm it as soon as possible, as there is a huge difference between the two.
If it were just drugs purchased from outside, it would be better and not seem so exaggerated.
Drug acquisitions are very normal. Major pharmaceutical giants make acquisitions every year, ranging from a few hundred million dollars to tens of billions of dollars. It is nothing new.
The acquisition of readily available drugs outside can only be attributed to the wealth of Antai Pharmaceutical Group, and nothing else matters at all.
But if this drug is a new drug developed by Chen Xuan himself, then the meaning is completely different.
This proves that Antai Pharmaceutical Group's R&D capabilities have reached a top-notch level, and are not inferior to pharmaceutical giants from various countries.
vstars